| Autor: |
Elena Castellano, Donatella Gaviglio, Micaela Pellegrino, Laura Gianotti, Giampaolo Magro, Francesco Tassone, Claudia Baffoni, Renza Sibbono, Roberto Attanasio, Alberto Boriano, Giorgio Borretta |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Endocrine, Metabolic & Immune Disorders - Drug Targets. 22:1313-1318 |
| ISSN: |
1871-5303 |
| DOI: |
10.2174/1871530322666220104100944 |
| Popis: |
Background: The discharge from the hospital of insulin-treated hyperglycemic patients is always challenging. This is even more so in patients requiring glucocorticoid treatment, such as those with COVID-19. Patients and Method: A retrospective monocentric study of 23 inpatients was conducted with newly diagnosed or already known diabetes mellitus (DM) who were naïve to insulin treatment, and who were hospitalized with COVID-19 in non-critical settings and then discharged. Patients were followed up for one month after discharge for the management of insulin treatment by a multi-professional team through phone consultations. Results: Insulin prescriptions at discharge were 24.6 ± 14 U/day injected in 2 ± 1.5 daily shots. A mean of three phone consultations was required. One month later, the mean insulin reduction was 1.5 ± 1.3 shots and 6 ± 5 U/day. All patients reached their glycemic target without hypoglycemic events, drop-outs, or readmissions. Conclusion: This study demonstrates the feasibility, efficacy, and safety of a multi-professional approach through telemedicine for managing DM patients after discharge during COVID-19. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
